Publications by authors named "P Tomasini"

Claim this Profile
T
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care.
Florence Ranchon, Florian Slimano, Maha Ayyoub, Charlotte Bérard, Anais Grand, Pascale Tomasini

Ann Pharm Fr· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amivantamab Plus Lazertinib in Atypical -Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2.
Pascale Tomasini, Yongsheng Wang, Yongsheng Li, Enriqueta Felip, Lin Wu

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysis.
Yohann Vincent, Faustine Enoch, Vanessa Pauly, Anne-Laure Couderc, Pascale Tomasini

Eur J Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial.
Byoung Chul Cho, Weimin Li, Alexander I Spira, Maxwell Sauder, Jill Feldman, Pascale Tomasini

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of sotorasib clinical efficacy in KRAS-mutated non-small-cell lung cancer.
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, David S Hong, Herve Lena, Pascale Tomasini

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis